Fig. 6From: Proteasome inhibitors modulate anticancer and anti-proliferative properties via NF-kB signaling, and ubiquitin-proteasome pathways in cancer cell lines of different organsThe log IC50 values for anti-proliferation properties of eleven compounds in prostate, breast and lung cancer cells. The log IC50 values calculated from original data of Tables 1-9 by GraphPad Prism 5 program. The left hand figure showed the logIC50 of first five compounds (thiostrepton, ampicillin, dexamethasone, 2-methoxyestradiol, δ-tocotrienol, and right hand figure indicated the remaining six compounds ((−) riboflavin, ascorbic acid, quercetin, amiloride, and quinine sulphate) of prostate, breast and lung cancer cellsBack to article page